ELI LILLY & Co — Director's Dealing 2025

Mar 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-03-01

Reporting Person: Hernandez Edgardo (EVP & Pres., Mfg. Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-01	Common Stock	M	2837	—	Acquired	41008.76	Direct
2025-03-01	Common Stock	F	1260.325	$920.63	Disposed	39748.435	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-01	Restricted Stock Unit	$	M	2837	Disposed	2025-03-01	Common Stock (2837)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	867.52	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.